Topical formulation containing chamomile microparticles with chitosan: study to assess safety and efficacy.

Phase 1

• Conditions: Radiodermatitis; Dermatitis; C17.800.174.826; C17.800.174

• Registration Number: RBR-3h78kz
• Lead Sponsor: Escola de Enfermagem de Ribeirão Preto da Universidade de São Paulo

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-10-21
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Data analysis completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Healthy volunteers; older than 18 years; with integrity skin in sites for the application of products; no history of allergic reactions to shrimp, fish or seafood; no history of allergic reactions to any component of chamomile; no history of allergic reactions to components of the formulations.

Exclusion Criteria

Volunteers in current treatment with heparin, oral anticoagulants and antiplatelet agents.

Study & Design

• Study Type: Intervention
• Study Design: Not specified